$32.84

-0.18 (-0.55%)

Weekly Expected Move ±2.8%

$31 $32 $33 $34 $35

NASDAQ · Healthcare · Medical - Instruments & Supplies · Tech Score Sell · Power 42 · $301.7M mcap · 3M float · 7.25% daily turnover · Short 57% of daily vol

Credit Risk of going bust: higher than 55% of companies Debt: 13.9% of company value Bonds: none of note held by US funds details ▾

Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.59 (down 98%), Sanara MedTech Inc. would be worth roughly what it owes.
Total debt $48.5M against a stock market value of $301.7M.
Distance to default 4.65 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $23.2M (short-term plus half of long-term), stock volatility 58.4%; Altman Z 3.72. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WIDE EDGE

70.5 / 100

NoneWeakNarrowWide

Primary source: Intangible Assets · ROIC: 19.8% · 5Y Avg: -18.0%

Cost Advantage

Intangibles

Switching Cost

Network Effect

Scale

The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. SMTI possesses a Wide competitive edge (70.5/100) — durable structural advantages that are difficult for competitors to erode. The primary source of advantage is Intangible Assets. ROIC of 19.8% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets

Low

$35

Avg Target

$35

High

Based on 3 analyst ratings (12 mo)

Analyst Recommendations

Strong Buy: 0Buy: 2Hold: 1Sell: 0Strong Sell: 0

Rating Summary

ConsensusBuy

Avg Target$35.00

Analysts2

Price Target Change History

Date	Firm	Analyst	Old	New	Change	Upside @ Call	Stock@Call
2026-07-30	Lake Street	—	$32	$35	+3	+3.3%	$33.90
2026-07-30	H.C. Wainwright	—	$54	$35	-19	+15.7%	$30.25
2026-04-15	Lake Street	—	Initiated	$32	—	+67.8%	$19.07
2025-08-18	H.C. Wainwright	Yi Chen	Initiated	$54	—	+81.9%	$29.68
2024-03-26	Cantor Fitzgerald	Ross Osborn	Initiated	$44	—	+19.7%	$36.75

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C-

Oct 27, 2026

DCF

ROE

ROA

D/E

P/E

P/B

The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. SMTI receives an overall rating of C-. Strongest factors: DCF (4/5). Areas of concern: ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).

Rating Change History

Date	From	To
2026-07-30	C	C-
2026-07-01	C-	C
2026-06-29	C	C-
2026-03-25	D+	C

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 32 Grade D

Profitability

Balance Sheet

Earnings Quality

Growth

Value

Momentum

Safety

Cash Flow

The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. SMTI scores highest in Safety (65/100) and lowest in Value (23/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score

2.76

Grey Zone

Piotroski F-Score

5/9

✗ ✓ ✗ ✓ ✗ ✓ ✗ ✓ ✓

Beneish M-Score

-5.17

Unlikely Manipulator

Ohlson O-Score

-2.22

Bankruptcy prob: 9.8%

Low Risk

Credit Rating

BB+

Score: 47.9/100

Trend: Improving

Earnings Quality

—

OCF/NI: -0.18x

Accruals: -44.9%

The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. SMTI scores 2.76, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. SMTI scores 5/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. SMTI's score of -5.17 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. SMTI's implied 9.8% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. SMTI receives an estimated rating of BB+ (score: 47.9/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E

-8.83x

PEG

0.03x

P/S

2.75x

P/B

35.81x

P/FCF

45.37x

P/OCF

35.89x

EV/EBITDA

24.31x

EV/Revenue

2.16x

EV/EBIT

32.60x

EV/FCF

52.72x

Earnings Yield

-15.67%

FCF Yield

2.20%

Shareholder Yield

0.06%

Graham Number

—

Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. SMTI currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden

111.833

NI / EBT

Interest Burden

-0.039

EBT / EBIT

EBIT Margin

0.066

EBIT / Rev

Asset Turnover

1.308

Rev / Assets

Equity Multiplier

3.874

Assets / Equity

ROE

-147.7%

The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. SMTI's ROE of -147.7% is driven by financial leverage (equity multiplier: 3.87x). Note: high leverage means ROE is amplified by debt rather than operational performance. A tax burden ratio of 111.83 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate

0.00%

Fair P/E

8.50x

Intrinsic Value

—

Price/Value

—

Margin of Safety

—

Premium

—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price

$32.84

Median 1Y

$32.15

5th Pctile

$11.05

95th Pctile

$95.32

Ann. Volatility

69.3%

Analyst Target

$35.00

25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

Executive	Salary	Stock	Total
Seth D. Yon President and Chief Executive Officer	$478,903	$1,318,742	$2,306,511
Jacob A. Waldrop Chief Operating Officer	$315,000	$306,244	$867,844
Suresh V. Muppalla Former President and Chief Executive Officer of Tissue Health Plus, LLC	$612,794	$103,014	$715,808
Elizabeth B. Taylor Chief Financial Officer	$240,545	$187,509	$637,054
Ronald T. Nixon Former Chief Executive Officer	$247,994	$262,485	$585,479

CEO Pay Ratio

3:1

CEO-to-Employee Pay Ratio

CEO Total Comp: $2,306,511

Avg Employee Cost (SGA/emp): $728,861

Employees: 108

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees

108

-23.4% YoY

Revenue / Employee

$954,796

Rev: $103,117,982

Profit / Employee

$-347,802

NI: $-37,562,606

SGA / Employee

$728,861

Avg labor cost proxy

R&D / Employee

$46,967

Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
ROE	-23.2%	-43.1%	-30.4%	-22.2%	-18.6%	-21.9%	-16.9%	-22.2%	-18.2%	-9.9%	-11.5%	-15.8%	-19.9%	-22.9%	-28.6%	-25.8%	-1.6%	-1.7%	-1.5%	-1.5%	-1.48%
ROA	-19.4%	-34.3%	-27.1%	-18.6%	-14.8%	-16.3%	-12.7%	-16.4%	-11.9%	-6.4%	-7.5%	-10.0%	-10.2%	-11.9%	-13.7%	-11.5%	-47.0%	-46.7%	-40.5%	-38.1%	-38.13%
ROIC	-31.7%	-46.9%	-54.1%	-37.9%	-28.1%	-29.4%	-23.7%	-20.1%	-11.3%	-6.5%	-6.9%	-8.5%	-9.4%	-9.5%	-9.5%	-5.5%	1.0%	7.9%	16.0%	19.8%	19.78%
ROCE	-14.6%	-24.6%	-31.6%	-28.7%	-24.2%	-25.0%	-22.2%	-20.3%	-12.3%	-11.6%	-11.8%	-12.2%	-10.7%	-8.5%	-8.3%	-4.8%	0.6%	2.7%	10.5%	12.9%	12.86%
Gross Margin	91.1%	88.9%	89.7%	90.1%	82.9%	84.5%	86.3%	86.1%	89.1%	89.9%	89.8%	90.0%	90.8%	91.4%	92.2%	92.5%	92.9%	90.8%	91.0%	93.0%	92.96%
Operating Margin	-31.8%	-48.5%	-35.5%	-35.0%	-24.8%	-20.4%	-7.8%	-11.8%	-5.7%	-1.3%	-8.3%	-14.3%	-8.9%	-1.4%	-8.9%	-0.1%	11.2%	10.5%	9.5%	6.3%	6.33%
Net Margin	-34.7%	-50.4%	-40.1%	8.0%	-11.3%	-26.8%	-7.6%	-11.6%	-6.6%	-1.3%	-9.5%	-17.4%	-13.2%	-5.8%	-15.1%	-7.8%	-1.2%	-5.8%	1.7%	-1.6%	-1.61%
EBITDA Margin	-28.3%	-45.7%	-33.0%	-28.8%	-17.7%	-13.1%	-5.7%	-9.0%	0.6%	-6.1%	-2.3%	-8.9%	-1.1%	4.6%	-4.6%	4.2%	13.6%	5.1%	10.0%	7.2%	7.17%
FCF Margin	-21.5%	-23.0%	-24.0%	-30.8%	-20.0%	-13.7%	-11.0%	-7.4%	-5.3%	-5.4%	-5.0%	-4.3%	-2.6%	-0.3%	-2.5%	0.1%	-0.8%	2.1%	3.1%	4.1%	4.10%
OCF Margin	-16.5%	-19.9%	-21.0%	-21.4%	-17.8%	-12.1%	-9.7%	-9.6%	-4.9%	-5.0%	-4.6%	-3.9%	-2.3%	-0.0%	-0.5%	3.8%	3.7%	6.6%	5.9%	5.2%	5.19%
ROE 3Y Avg	snapshot only																				-1.49%
ROE 5Y Avg	snapshot only																				-97.92%
ROA 3Y Avg	snapshot only																				-21.77%
ROIC 3Y Avg	snapshot only																				-3.88%
ROIC Economic	snapshot only																				14.96%
Cash ROA	snapshot only																				8.24%
Cash ROIC	snapshot only																				13.87%
CROIC	snapshot only																				10.97%
NOPAT Margin	snapshot only																				7.40%
Pretax Margin	snapshot only																				-0.26%
R&D / Revenue	snapshot only																				4.53%
SGA / Revenue	snapshot only																				76.89%
SBC / Revenue	snapshot only																				0.46%

Valuation

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
P/E Ratio	-55.80	-28.04	-21.95	-21.48	-32.62	-47.58	-56.33	-38.43	-31.74	-81.52	-63.71	-36.40	-30.80	-29.31	-23.15	-24.61	-7.57	-5.36	-4.60	-6.38	-8.834
P/S Ratio	11.77	9.20	8.04	5.61	6.41	8.24	6.30	5.53	4.14	5.40	4.58	3.30	3.30	3.27	2.89	2.51	2.78	1.95	1.44	1.86	2.748
P/B Ratio	7.60	7.25	7.46	4.70	5.30	9.03	8.10	8.02	5.85	7.82	7.20	5.73	6.47	7.19	7.21	6.91	46.20	33.96	21.96	25.73	35.813
P/FCF	-54.65	-39.92	-33.55	-18.22	-31.97	-59.93	-57.01	-74.93	-78.45	-99.92	-91.57	-76.11	-129.28	-1119.18	-114.31	4150.43	-327.78	93.17	45.76	45.37	45.373
P/OCF	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	67.04	75.18	29.67	24.43	35.89	35.886
EV/EBITDA	-53.53	-29.78	-24.02	-15.45	-21.27	-38.19	-41.55	-49.14	-62.62	-108.05	-112.64	-77.50	-76.99	-236.77	-149.90	287.13	66.33	46.94	21.41	24.31	24.308
EV/Revenue	10.77	8.45	7.45	5.20	6.16	8.06	6.20	5.46	4.23	5.50	4.71	3.44	3.50	3.46	3.15	2.81	3.10	2.26	1.76	2.16	2.162
EV/EBIT	-48.00	-27.28	-22.15	-13.89	-18.31	-30.68	-30.35	-33.11	-34.75	-51.19	-46.80	-33.14	-34.33	-48.42	-42.02	-68.25	1025.98	161.18	32.32	32.60	32.604
EV/FCF	-50.01	-36.65	-31.11	-16.90	-30.72	-58.63	-56.14	-74.02	-80.15	-101.81	-94.18	-79.34	-137.13	-1184.01	-124.69	4634.05	-365.27	107.80	56.07	52.72	52.724
Earnings Yield	-1.8%	-3.6%	-4.6%	-4.7%	-3.1%	-2.1%	-1.8%	-2.6%	-3.2%	-1.2%	-1.6%	-2.7%	-3.2%	-3.4%	-4.3%	-4.1%	-13.2%	-18.7%	-21.7%	-15.7%	-15.67%
FCF Yield	-1.8%	-2.5%	-3.0%	-5.5%	-3.1%	-1.7%	-1.8%	-1.3%	-1.3%	-1.0%	-1.1%	-1.3%	-0.8%	-0.1%	-0.9%	0.0%	-0.3%	1.1%	2.2%	2.2%	2.20%
PEG Ratio	snapshot only																				0.029
EV/OCF	snapshot only																				41.700
EV/Gross Profit	snapshot only																				2.353
Acquirers Multiple	snapshot only																				23.100
Shareholder Yield	snapshot only																				0.06%

Leverage & Solvency

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Current Ratio	6.55	4.09	4.30	2.86	2.23	1.61	1.79	1.84	1.46	1.38	1.35	1.80	2.23	2.18	2.77	2.26	1.80	1.80	2.28	2.58	2.577
Quick Ratio	6.17	3.75	3.89	2.53	1.83	1.33	1.47	1.39	1.09	1.04	1.02	1.49	2.02	2.00	2.54	2.03	1.60	1.59	2.05	2.30	2.300
Debt/Equity	0.01	0.01	0.01	0.01	0.02	0.02	0.05	0.05	0.27	0.26	0.27	0.39	0.80	0.82	1.22	1.28	7.72	8.13	6.88	6.11	6.109
Net Debt/Equity	-0.65	-0.59	-0.54	-0.34	-0.21	-0.19	-0.12	-0.10	0.13	0.15	0.20	0.24	0.39	0.42	0.66	0.80	5.28	5.33	4.95	4.17	4.168
Debt/Assets	0.01	0.01	0.01	0.01	0.01	0.01	0.04	0.04	0.16	0.16	0.16	0.22	0.36	0.37	0.46	0.46	0.67	0.66	0.70	0.70	0.702
Debt/EBITDA	-0.11	-0.06	-0.04	-0.03	-0.08	-0.08	-0.26	-0.31	-2.80	-3.56	-4.11	-5.06	-9.00	-25.51	-23.23	47.80	9.94	9.71	5.48	4.97	4.968
Net Debt/EBITDA	4.97	2.66	1.89	1.21	0.87	0.84	0.65	0.60	-1.33	-2.01	-3.12	-3.15	-4.41	-12.96	-12.48	29.97	6.81	6.37	3.94	3.39	3.389
Interest Coverage	-3706.59	-10513.77	—	—	-115.17	-54.43	-49.42	-44.47	-25.43	-14.68	-9.21	-5.42	-3.74	-1.98	-1.64	-0.75	0.12	0.46	1.62	2.01	2.009
Equity Multiplier	1.12	1.19	1.17	1.28	1.35	1.46	1.44	1.42	1.70	1.65	1.64	1.76	2.23	2.24	2.63	2.79	11.58	12.30	9.86	8.70	8.705
Cash Ratio	snapshot only																				1.234
Debt Service Coverage	snapshot only																				2.695
Cash to Debt	snapshot only																				0.318
FCF to Debt	snapshot only																				0.093
Defensive Interval	snapshot only																				112.7 days

Efficiency & Turnover

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Asset Turnover	0.92	1.04	0.74	0.71	0.76	0.94	1.14	1.14	0.91	0.96	1.04	1.10	0.95	1.07	1.09	1.13	1.28	1.28	1.30	1.31	1.308
Inventory Turnover	1.72	1.45	1.58	1.59	1.81	2.27	2.74	2.65	1.93	1.90	1.99	1.86	1.91	2.18	2.19	2.26	2.47	2.44	2.82	2.56	2.556
Receivables Turnover	10.74	9.19	8.88	9.28	9.60	9.36	10.66	10.59	9.64	8.50	8.67	8.13	8.41	8.30	8.70	8.60	8.78	8.45	8.44	8.94	8.938
Payables Turnover	4.91	4.25	3.92	3.31	6.94	6.30	5.48	6.88	5.76	4.58	5.06	7.41	4.44	4.65	4.92	6.81	6.03	4.27	5.88	6.23	6.233
DSO	34	40	41	39	38	39	34	34	38	43	42	45	43	44	42	42	42	43	43	41	40.8 days
DIO	212	252	231	229	202	161	133	138	189	192	184	196	191	167	167	161	148	149	129	143	142.8 days
DPO	74	86	93	110	53	58	67	53	63	80	72	49	82	79	74	54	61	86	62	59	58.6 days
Cash Conversion Cycle	171	206	179	159	187	142	101	119	164	155	153	192	152	133	135	150	129	107	110	125	125.1 days
Fixed Asset Turnover	snapshot only																				47.006
Operating Cycle	snapshot only																				183.6 days
Cash Velocity	snapshot only																				7.121
Capital Intensity	snapshot only																				0.630

Growth (YoY)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue	54.8%	54.9%	57.8%	48.9%	71.5%	89.9%	98.7%	96.6%	66.7%	41.8%	27.0%	21.4%	24.7%	33.4%	34.7%	34.3%	30.6%	19.0%	17.4%	12.9%	12.93%
Net Income	17.1%	-81.8%	-1.7%	-1.1%	-59.7%	-0.2%	39.3%	-8.3%	-10.8%	45.8%	18.3%	23.5%	-2.3%	-1.2%	-1.3%	-51.4%	-3.5%	-2.9%	-1.9%	-2.2%	-2.22%
EPS	30.8%	-50.7%	-1.4%	-94.3%	-48.1%	9.2%	43.6%	-7.4%	-7.8%	47.3%	20.7%	25.7%	-0.1%	-1.2%	-1.3%	-48.8%	-3.3%	-2.8%	-1.8%	-2.2%	-2.20%
FCF	26.0%	-9.6%	-71.9%	-1.7%	-59.6%	-13.2%	8.4%	52.9%	56.1%	44.3%	42.5%	28.7%	39.7%	92.8%	32.0%	1.0%	56.6%	9.5%	2.5%	75.4%	75.45%
EBITDA	16.5%	-47.5%	-1.1%	-1.6%	-1.5%	-41.3%	4.4%	35.1%	61.1%	65.8%	64.4%	51.5%	16.2%	61.7%	32.3%	1.3%	2.3%	4.9%	5.6%	9.3%	9.27%
Op. Income	14.7%	-46.5%	-1.1%	-1.7%	-1.7%	-69.7%	-20.8%	17.4%	44.5%	66.3%	58.7%	41.2%	7.7%	-59.3%	-60.3%	20.5%	1.1%	1.6%	2.2%	3.3%	3.33%
OCF Growth	snapshot only																				56.12%
Asset Growth	snapshot only																				-29.99%
Equity Growth	snapshot only																				-77.56%
Debt Growth	snapshot only																				6.77%
Shares Change	snapshot only																				0.58%

Growth (CAGR)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue 3Y	43.0%	60.5%	61.8%	62.1%	64.3%	57.4%	61.1%	67.2%	64.2%	61.0%	58.5%	52.6%	52.8%	53.1%	50.3%	47.4%	39.5%	31.0%	26.1%	22.6%	22.57%
Revenue 5Y	37.4%	34.4%	35.0%	37.3%	42.7%	48.7%	51.7%	51.5%	52.9%	61.9%	60.6%	59.0%	56.0%	49.1%	48.2%	50.1%	48.4%	45.9%	44.5%	40.0%	40.05%
EPS 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EBITDA 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EBITDA 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Gross Profit 3Y	43.2%	60.0%	61.4%	62.5%	63.3%	55.5%	58.6%	64.3%	62.3%	59.9%	58.0%	52.2%	52.4%	53.2%	50.9%	48.4%	42.1%	34.0%	29.1%	25.8%	25.77%
Gross Profit 5Y	40.9%	36.8%	36.7%	38.6%	43.2%	48.3%	51.1%	50.2%	51.6%	60.7%	59.9%	59.2%	56.4%	49.5%	48.6%	50.8%	49.3%	46.7%	45.1%	40.5%	40.50%
Op. Income 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Op. Income 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
OCF 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
OCF 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Assets 3Y	1.2%	1.3%	1.2%	1.4%	1.4%	76.4%	84.7%	79.4%	98.5%	95.9%	22.0%	23.7%	32.7%	34.3%	41.6%	28.6%	5.0%	6.1%	4.9%	5.9%	5.87%
Assets 5Y	84.0%	75.7%	75.8%	87.8%	96.3%	94.1%	94.2%	90.9%	82.9%	89.3%	85.2%	84.0%	83.0%	51.3%	58.9%	57.8%	49.1%	49.3%	12.2%	12.3%	12.26%
Equity 3Y	1.8%	2.0%	—	—	—	84.9%	83.1%	91.7%	96.4%	93.9%	6.4%	5.9%	5.5%	8.7%	8.1%	-0.7%	-48.7%	-47.9%	-44.7%	-42.2%	-42.21%
Book Value 3Y	88.6%	1.1%	—	—	—	68.1%	67.0%	74.5%	78.7%	74.6%	-0.9%	1.7%	1.2%	4.3%	3.9%	-2.5%	-50.3%	-48.5%	-46.4%	-43.2%	-43.19%
Dividend 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

Growth Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue Stability	0.83	0.83	0.82	0.83	0.80	0.79	0.78	0.79	0.84	0.89	0.90	0.91	0.94	0.94	0.95	0.96	0.98	1.00	1.00	0.99	0.993
Earnings Stability	0.65	0.85	0.78	0.87	0.90	0.96	0.71	0.90	0.91	0.48	0.31	0.63	0.84	0.46	0.34	0.58	0.53	0.50	0.53	0.57	0.571
Margin Stability	0.95	0.96	0.97	0.98	0.98	0.98	0.98	0.98	0.98	0.98	0.98	0.98	0.98	0.98	0.98	0.97	0.97	0.97	0.97	0.97	0.969
Rev. Growth Consistency	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.000
Earn. Growth Consistency	0.50	0.00	0.00	0.00	0.00	0.00	0.50	0.00	0.00	0.50	1.00	0.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.000
FCF Positive Streak	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0
Earnings Persistence	0.93	0.50	0.50	0.50	0.50	1.00	0.84	0.97	0.96	0.82	0.93	0.91	0.99	0.50	0.50	0.50	0.50	0.50	0.50	0.50	0.500
Earnings Smoothness	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
ROE Trend	—	0.31	0.04	0.28	0.38	0.29	0.08	-0.05	-0.04	0.13	0.13	0.06	-0.04	-0.10	-0.18	-0.10	-5.91	-6.16	-4.56	-3.81	-3.811
Gross Margin Trend	0.01	0.01	0.00	-0.00	-0.03	-0.04	-0.04	-0.05	-0.03	-0.00	0.01	0.02	0.03	0.04	0.04	0.04	0.04	0.03	0.02	0.01	0.011
FCF Margin Trend	0.15	0.14	0.15	0.05	0.13	0.14	0.12	0.16	0.16	0.13	0.12	0.15	0.10	0.09	0.05	0.06	0.03	0.05	0.07	0.06	0.062
Sustainable Growth Rate	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Internal Growth Rate	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

Cash Flow Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
OCF/Net Income	0.78	0.61	0.57	0.82	0.91	0.70	0.87	0.67	0.37	0.75	0.63	0.43	0.22	0.00	0.04	-0.37	-0.10	-0.18	-0.19	-0.18	-0.178
FCF/OCF	1.30	1.16	1.14	1.44	1.12	1.13	1.14	0.77	1.09	1.08	1.10	1.13	1.10	10.64	5.40	0.02	-0.23	0.32	0.53	0.79	0.791
FCF/Net Income	snapshot only																				-0.141
OCF/EBITDA	snapshot only																				0.583
CapEx/Revenue	5.0%	3.1%	2.9%	9.4%	2.2%	1.6%	1.4%	2.3%	0.4%	0.4%	0.4%	0.5%	0.2%	0.3%	2.1%	3.7%	4.6%	4.5%	2.7%	1.1%	1.08%
CapEx/Depreciation	snapshot only																				0.479
Accruals Ratio	-0.04	-0.13	-0.12	-0.03	-0.01	-0.05	-0.02	-0.05	-0.07	-0.02	-0.03	-0.06	-0.08	-0.12	-0.13	-0.16	-0.52	-0.55	-0.48	-0.45	-0.449
Sloan Accruals	snapshot only																				-0.019
Cash Flow Adequacy	snapshot only																				4.783

Dividends & Buybacks

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Dividend Yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Dividend/Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Payout Ratio	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF Payout Ratio	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	0.0%	—	0.0%	0.0%	0.0%	0.00%
Total Payout Ratio	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Div. Increase Streak	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Chowder Number	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Buyback Yield	0.0%	0.2%	0.2%	0.3%	0.2%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.1%	0.06%
Net Buyback Yield	-11.2%	-12.8%	0.2%	0.3%	0.2%	0.0%	-0.2%	-0.3%	-0.4%	-0.3%	-0.1%	-0.1%	-0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.1%	0.06%
Total Shareholder Return	-11.2%	-12.8%	0.2%	0.3%	0.2%	0.0%	-0.2%	-0.3%	-0.4%	-0.3%	-0.1%	-0.1%	-0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.1%	0.06%

DuPont Factors

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Tax Burden (NI/EBT)	0.98	0.99	0.99	0.65	0.55	0.57	0.50	0.82	0.98	0.97	0.97	0.98	0.99	0.98	0.98	0.98	5.85	6.46	17.73	111.83	111.833
Interest Burden (EBT/EBIT)	0.96	1.07	1.10	1.07	1.06	1.16	1.10	1.06	1.09	0.64	0.73	0.89	1.06	1.60	1.70	2.53	-20.81	-4.03	-0.32	-0.04	-0.039
EBIT Margin	-0.22	-0.31	-0.34	-0.37	-0.34	-0.26	-0.20	-0.17	-0.12	-0.11	-0.10	-0.10	-0.10	-0.07	-0.07	-0.04	0.00	0.01	0.05	0.07	0.066
Asset Turnover	0.92	1.04	0.74	0.71	0.76	0.94	1.14	1.14	0.91	0.96	1.04	1.10	0.95	1.07	1.09	1.13	1.28	1.28	1.30	1.31	1.308
Equity Multiplier	1.20	1.26	1.12	1.20	1.25	1.34	1.33	1.35	1.53	1.56	1.54	1.59	1.95	1.92	2.09	2.23	3.48	3.55	3.79	3.87	3.874

Per Share

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
EPS (Diluted TTM)	$-0.61	$-1.05	$-1.30	$-0.97	$-0.91	$-0.96	$-0.73	$-1.04	$-0.98	$-0.50	$-0.58	$-0.78	$-0.98	$-1.13	$-1.33	$-1.15	$-4.19	$-4.36	$-3.74	$-3.70	$-3.70
Book Value/Share	$4.51	$4.08	$3.82	$4.43	$5.61	$5.04	$5.09	$5.00	$5.32	$5.25	$5.14	$4.92	$4.67	$4.62	$4.28	$4.11	$0.69	$0.69	$0.78	$0.92	$0.92
Tangible Book/Share	$3.87	$3.45	$3.21	$1.77	$1.23	$0.81	$0.88	$0.90	$-0.63	$-0.43	$-0.51	$-0.58	$-0.69	$-0.61	$-1.04	$-1.07	$-2.08	$-1.89	$-1.61	$-1.49	$-1.49
Revenue/Share	$2.91	$3.21	$3.54	$3.72	$4.63	$5.52	$6.55	$7.25	$7.51	$7.61	$8.08	$8.55	$9.16	$10.16	$10.68	$11.29	$11.40	$11.96	$11.96	$12.68	$12.68
FCF/Share	$-0.63	$-0.74	$-0.85	$-1.14	$-0.93	$-0.76	$-0.72	$-0.54	$-0.40	$-0.41	$-0.40	$-0.37	$-0.23	$-0.03	$-0.27	$0.01	$-0.10	$0.25	$0.38	$0.52	$0.52
OCF/Share	$-0.48	$-0.64	$-0.74	$-0.79	$-0.83	$-0.67	$-0.63	$-0.70	$-0.37	$-0.38	$-0.37	$-0.33	$-0.21	$-0.00	$-0.05	$0.42	$0.42	$0.79	$0.70	$0.66	$0.66
Cash/Share	$2.98	$2.48	$2.12	$1.55	$1.27	$1.08	$0.89	$0.74	$0.75	$0.60	$0.34	$0.73	$1.91	$1.86	$2.41	$1.97	$1.67	$1.92	$1.51	$1.78	$1.78
EBITDA/Share	$-0.59	$-0.91	$-1.10	$-1.25	$-1.34	$-1.17	$-0.98	$-0.81	$-0.51	$-0.39	$-0.34	$-0.38	$-0.42	$-0.15	$-0.22	$0.11	$0.53	$0.58	$0.98	$1.13	$1.13
Debt/Share	$0.06	$0.06	$0.05	$0.04	$0.11	$0.10	$0.26	$0.25	$1.42	$1.38	$1.39	$1.92	$3.75	$3.78	$5.22	$5.28	$5.30	$5.59	$5.38	$5.60	$5.60
Net Debt/Share	$-2.91	$-2.42	$-2.07	$-1.52	$-1.16	$-0.98	$-0.63	$-0.49	$0.67	$0.78	$1.05	$1.20	$1.84	$1.92	$2.80	$3.31	$3.63	$3.67	$3.87	$3.82	$3.82

Academic Models

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Altman Z-Score	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	2.764
Altman Z-Prime	snapshot only																				2.552
Piotroski F-Score	5	4	3	3	2	3	3	3	4	4	4	4	5	5	4	5	4	3	3	5	5
Beneish M-Score	-2.12	-2.46	-2.10	-1.35	-0.47	-0.84	-1.07	-1.91	-2.43	-2.11	-2.17	-2.26	-2.17	-2.51	-2.77	-2.98	-5.32	-5.53	-5.19	-5.17	-5.171
Ohlson O-Score	snapshot only																				-2.221
Net-Net WC	snapshot only																				$-3.35
EVA	snapshot only																				$4015815.93

Credit

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Credit Rating	snapshot only																				BB+
Credit Score	56.77	57.17	68.98	69.77	57.29	56.24	55.58	55.76	53.54	53.75	54.16	55.04	50.07	52.20	49.38	37.19	31.58	28.57	38.97	47.95	47.947
Credit Grade	snapshot only																				11
Credit Trend	snapshot only																				10.760
Implied Spread (bps)	snapshot only																				400.000
Industry Credit Rank	snapshot only																				31
Sector Credit Rank	snapshot only																				44

SMTI NASDAQ

Edge Score

Analyst Insights

Financial Rating

InsiderStreet Scorecard

Risk & Quality Signals

Valuation

DuPont Decomposition (5-Factor)

Graham-Dodd Adjusted Valuation

Profitability Trends

Leverage & Solvency Trends

Efficiency & Working Capital Trends

Growth Trends (YoY %)

Earnings Stability

Monte Carlo Price Simulation

Executive Compensation

C-Suite Compensation

CEO Pay Ratio

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Scaling Efficiency

Sign in to InsiderStreet